About Bifidobacterium
Bifidobacterium is a company based in Panchkula (India) founded in 2022. It operates as a B2B. Bifidobacterium offers products and services including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements. Bifidobacterium operates in a competitive market with competitors including Roquette, DENAVA, Cortalix, MVMD and Winclove, among others.
- Headquarter Panchkula, India
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Fido Pharma Private Limited
- Date of Incorporation 04 Mar, 2020
- Jurisdiction Panchkula, Haryana, India
-
Annual Revenue
$2.41 M (USD)189.93as on Mar 31, 2024
-
Net Profit
$475.76 K (USD)790.75as on Mar 31, 2024
-
EBITDA
$571.37 K (USD)410.14as on Mar 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bifidobacterium
Bifidobacterium offers a comprehensive portfolio of products and services, including Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.
Enzymes for industrial applications in health and food processing.
Probiotics to enhance digestive health and immune function.
Blended probiotics for targeted health benefits.
Nutraceuticals supporting overall wellness and nutrition.
Supplements derived from probiotics for daily health maintenance.
Funding Insights of Bifidobacterium
Detailed funding history for Bifidobacterium
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bifidobacterium
Investment portfolio details for Bifidobacterium
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bifidobacterium
Detailed financials for Bifidobacterium
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bifidobacterium Comparisons
Peer comparison for Bifidobacterium
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bifidobacterium
Bifidobacterium operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Roquette, DENAVA, Cortalix, MVMD and Winclove, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Plant-based pharma, nutraceuticals, and cosmetics are manufactured as a CDMO.
|
|
| Locked | Locked | Locked |
Investments are managed in health and digital sectors.
|
|
| Locked | Locked | Locked |
Biotechnological company developing radiopharmaceuticals and diagnostics based on single-domain antibodies for applications in immunoPET imaging and targeted radiotherapeutics
|
|
| Locked | Locked | Locked |
Biotech company focused on manufacturing neutraceuticals
|
|
| Locked | Locked | Locked |
Probiotic food supplements are developed and produced by Winclove.
|
|
| Locked | Locked | Locked |
Manufacturer of weight loss and energy supplements
|
Detailed competitors of Bifidobacterium
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bifidobacterium
Complete news archive for Bifidobacterium
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bifidobacterium
Bifidobacterium was founded in 2022.
Bifidobacterium is headquartered in Panchkula, India. It is registered at Panchkula, Haryana, India.
Annual revenue of Bifidobacterium is $2.41M as on Mar 31, 2024.
Fido Pharma Private Limited produces enzyme solutions and probiotics for applications in biopharmaceutical, fine chemicals, food and feed, and cosmetics industries. They focus on high-quality manufacturing and supply to support health benefits like digestive health and immunity. Based in Panchkula, India, with additional sites in Hyderabad, they serve global customers through B2B channels, emphasizing innovation in health supplements.
Bifidobacterium offers Enzymes, Probiotics, Probiotics Blends, Nutraceuticals, and Dietary Supplements.